Protagonist Therapeutics announced topline results from the Phase 2 IDEAL study evaluating PN-943 in patients with moderate-to-severe ulcerative colitis (UC).
Also Read: Glass Lewis Proxy...
CoNextions Inc. , an innovator in tendon repair, is pleased to announce that CoNextions TR Tendon Repair System has received FDA 510(k) Clearance. Expected...
TeDan Surgical Innovations (TSI), leader in the development and commercialization of surgical access systems continues to address evolving surgical access techniques to the spine...
